Skip to main content

Advertisement

Table 2 miRNAs differentially expressed between normal colon and early stage colorectal cancer (Stages I and II).

From: Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer

miRNA Normal Stage I/II Fold change p-value
hsa-miR-224 6.89 8.67 3.45 1.80E-02
hsa-miR-21 13.02 14.49 2.78 1.52E-04
hsa-miR-34a 9.48 10.43 1.92 1.92E-02
hsa-miR-106a 10.68 11.57 1.85 2.88E-02
hsa-miR-18a 7.51 8.38 1.83 3.32E-02
hsa-miR-29b 9.70 10.56 1.82 3.27E-03
hsa-miR-19b 10.84 11.69 1.80 2.77E-02
hsa-miR-106b 9.45 10.26 1.76 1.37E-02
hsa-miR-20a 9.28 10.06 1.72 3.75E-02
hsa-miR-29a 12.14 12.89 1.68 9.84E-04
hsa-miR-181b 8.41 9.11 1.63 9.47E-03
hsa-miR-19a 7.78 8.45 1.60 2.58E-02
hsa-miR-95 6.12 6.79 1.59 3.33E-02
hsa-miR-516-3p 4.87 5.52 1.57 3.20E-02
hsa-miR-378* 7.53 6.85 0.62 1.87E-03
hsa-miR-422b 10.88 10.02 0.55 4.91E-03
hsa-miR-422a 10.05 9.19 0.55 9.57E-03
hsa-miR-30a-3p 7.14 6.24 0.54 1.51E-02
hsa-miR-139 7.62 6.17 0.37 5.75E-03
hsa-miR-195 11.04 9.52 0.35 2.37E-02
hsa-miR-145 15.11 13.46 0.32 4.30E-02
hsa-miR-133a 10.51 7.64 0.14 3.00E-02
  1. Fold change = cancer:normal